Aging biology, lifespan extension, hallmarks of aging, and healthspan optimization
4,123 articles
A Lancet commentary exposes how future physicians are discouraged from voicing views on assisted dying — with real consequences for medicine.
Science publishes an erratum correcting a 2026 research article on detecting supramolecular organic nanoparticles during heat wave events.
Researchers propose five criteria to identify the best immune aging biomarkers, with inflammaging scores and functional assays emerging as top candidates.
A comprehensive review reveals how gut bacteria harbor, spread, and amplify antibiotic resistance genes—and outlines emerging strategies to fight back.
A 2025 review maps how gut bacteria and their metabolites protect against radiotherapy damage—and how microbial therapies could transform cancer treatment.
A 2025 review reframes dietary protein quality as a multifaceted metric—digestibility, EAA density, and bioavailability—with major implications for aging adults.
A new stepwise feeding framework aligns nutrition delivery with three metabolic phases of critical illness, challenging one-size-fits-all ICU feeding.
A landmark study across US and UK populations identifies gut microbiome species consistently tied to cardiometabolic risk, diet quality, and disease markers.
Mesenchymal stem cells modulate immunity and reduce kidney damage in lupus nephritis, with clinical trials showing real but inconsistent gains.
A new review reveals how aged hematopoietic stem cells disrupt immune balance and impair regeneration in brain, muscle, and skin.
A 2025 review maps the integrin signaling pathways governing how mesenchymal stem cells differentiate—with implications for tissue engineering and regenerative medicine.
Glioma-associated mesenchymal stem cells suppress immunity and drive tumor growth — but may also be engineered into powerful cancer therapies.
